Enhanced green fluorescent protein as selectable marker of retroviral- mediated gene transfer in immature hematopoietic bone marrow cells

Blood

Volumn 90, Issue 9, 1997, Pages 3304-3315

  Bierhuizen, Marti F A ^a   Westerman, Yvonne ^a   Visser, Trudi P ^a   Dimjati, Wati ^a   Wognum, Albertus W ^a   Wagemaker, Gerard ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; CELL STRAIN 3T3; COLONY FORMING UNIT GM; COLONY FORMING UNIT S; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTER; GENE TRANSFER; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS;

EID: 0030783593     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.9.3304     Document Type: Article

References (63)

1. Nienhuis AW, McDonagh KT, Bodine DM: Gene transfer into hematopoietic stem cells. Cancer 67:2700, 1991
2. Einerhand MPW, Valerio D: Gene transfer into hematopoietic stem cells: Prospects for human gene therapy. Curr Top Microbiol Immunol 177:217, 1992
3. Kerr WG, Mulé JJ: Gene therapy: Current status and future prospects. J Leukoc Biol 56:210, 1994
4. Vile RG, Russell SJ: Retroviruses as vectors. Br Med Bull 51:12, 1995
5. Brenner MK, Cunningham JM, Sorrentino BP, Heslop HE: Gene transfer into human hemopoietic progenitor cells. Br Med Bull 51:167, 1995
6. Dunbar CE, Emmons RVB: Gene transfer into hematopoietic progenitor and stem cells: Progress and problems. Stem Cells 12:563, 1994
7. Miller DG, Adam MA, Miller AD: Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 10:4239, 1990
8. Springett GM, Moen RC, Anderson S, Blaese RM, Anderson WF: Infection efficiency of T lymphocytes with amphotropic retroviral vectors is cell cycle dependent. J Virol 63:3865, 1989
9. Stead RB, Kwok WW, Storb R, Miller AD: Canine model for gene therapy: Inefficient gene expression in dogs reconstituted with autologous marrow infected with retroviral vectors. Blood 71:742, 1988
10. Challita P-M, Kohn DB: Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo. Proc Natl Acad Sci USA 91:2567, 1994
11. Ogawa M: Differentiation and proliferation of hematopoietic stem cells. Blood 81:2844, 1993
12. Lemischka IR: The haematopoietic stem cell and its clonal progeny: Mechanisms regulating the hierarchy of primitive haematopoietic cells. Cancer Surveys 15:3, 1992
13. Szilvassy SJ, Cory S: Efficient retroviral gene transfer to purified long-term repopulating hematopoietic stem cells. Blood 84:74, 1994
14. Williams DA, Lemischka IR, Nathan DG, Mulligan RC: Introduction of new genetic material into pluripotent haematopoietic stem cells of the mouse. Nature 310:476, 1984
15. Jordan CT, Lemischka IR: Clonal and systemic analysis of long-term hematopoiesis in the mouse. Genes Dev 4:220, 1990
16. Van Beusechem VW, Kukler A, Heidt PJ, Valerio D: Long-term expression of human adenosine deaminase in rhesus monkeys transplanted with retro virus-infected bone-marrow cells. Proc Natl Acad Sci USA 89:7640, 1992
17. Carter RF, Abrams-Ogg CG, Dick JE, Kruth SA, Valli VE, Kamel-Reid S, Dubé ID: Autologous transplantation of canine long-term marrow culture cells genetically marked by retroviral vectors. Blood 79:356, 1992
18. Dunbar CE, Cottler-Fox M, O'Shaughnessy JA, Doren S, Carter C, Berenson R, Brown S, Moen RC, Greenblatt J, Stewart FM, Leitman SF, Wilson WH, Cowan K, Young NS, Nienhuis AW: Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. Blood 85:3048, 1995
19. Brenner MK, Rill DR, Holladay MS, Heslop HE, Moen RC, Buschle M, Krance RA, Santana VM, Anderson WF, Ihle JN: Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients. Lancet 342:1134, 1993
20. Brenner MK, Rill DR, Moen RC, Krance RA, Mirro J Jr, Anderson WF, Ihle JN: Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet 341:85, 1993
21. Brenner MK: The contribution of marker gene studies to hemopoietic stem cell therapies. Stem Cells 13:453, 1995
22. Strair RK, Towle M, Smith BR: Retroviral mediated gene transfer into bone marrow progenitor cells: Use of beta-galactosidase as a selectable marker. Nucleic Acids Res 18:4759, 1990
23. Nolan GP, Fiering S, Nicolas J-F, Herzenberg LA: Fluorescence-activated cell analysis and sorting of viable mammalian cells based on β-D-galactosidase activity after transduction of Escherichia colt lacZ. Proc Natl Acad Sci USA 85:2603, 1988
24. Staal FJT, Bakker AQ, Verkuijlen M, Van Oort E, Spits H: Use of bicistronic retroviral vectors encoding the LacZ gene together with a gene of interest: A method to select producer cells and follow transduced target cells. Cancer Gene Ther 3:345, 1996
25. Staal FJT, Res PCM, Weijer K, Spits H: Development of retrovirally marked human T progenitor cells into mature thymocytes. Int Immunol 7:1301, 1995
26. + cells. Blood 84:1408, 1994
27. Conneally E, Bardy P, Eaves CJ, Thomas T, Chappel S, Shpall EJ, Humphries RK: Rapid and efficient selection of human hematopoietic cells expressing murine heat-stable antigen as.an indicator of retroviral-mediated gene transfer. Blood 87:456, 1996
28. Pawliuk R, Kay R, Lansdorp P, Humphries RK: Selection of retrovirally transduced hematopoietic cells using CD24 as a marker of gene transfer. Blood 84:2868, 1994
29. Mavilio F, Ferrari G, Rossini S, Nobili N, Bonini C, Casorati G, Traversari C, Bordignon C: Peripheral blood lymphocytes as target cells of retroviral vector-mediated gene transfer. Blood 83:1988, 1994
30. Chalfie M, Tu Y, Euskirchen G, Ward WW, Prasher DC: Green fluorescent protein as a marker for gene expression. Science 263:802, 1994
31. Prasher DC, Eckenrode VK, Ward WW, Prendergast FG, Cormier MJ: Primary structure of the Aequorea victoria green-fluorescent protein. Gene 111:229, 1992
32. Morin JG, Hastings JW: Energy transfer in a bioluminescent system. J Cell Physiol 77:313, 1971
33. Ward WW, Cody CW, Hart RC, Cormier MJ: Spectrophotometric identity of the energy-transfer chromophores in Renilla and Aequorea green fluorescent proteins. Photochem Photobiol 31:611, 1980
34. Delagrave S, Hawtin RE, Silva CM, Yang MM, Youvan DC: Red-shifted excitation mutants of the green fluorescent protein. BioTechnology 13:151, 1995
35. Heim R, Tsien RY: Engineering green fluorescent protein for improved brightness, longer wavelengths and fluorescence resonance energy transfer. Curr Biol 6:178, 1996
36. Zhang G, Gurtu V, Kain SR: An enhanced green fluorescent protein allows sensitive detection of gene transfer in mammalian cells. Biochem Biophys Res Commun 227:707, 1996
37. Cormack BP, Valdivia RH, Falkow S: FACS-optimized mutants of the green fluorescent protein (GFP). Gene 173:33, 1996
38. Cheng L, Fu J, Tsukamoto A, Hawley RG: Use of green fluorescent protein variants to monitor gene transfer and expression in mammalian cells. Nature Biotechnol 14:606, 1996
39. Levy JP, Muldoon RR, Zolotukhin S, Link CJ Jr: Retroviral transfer and expression of a humanized, red-shifted green fluorescent protein gene into human tumor cells. Nature Biotechnol 14:610, 1996
40. Lybarger L, Dempsey D, Franek KJ, Chervenak R: Rapid generation and flow cytometric analysis of stable GFP-expressing cells. Cytometry 25:211, 1996
41. Bierhuizen MFA, Westerman Y, Visser TP, Wognum AW, Wagemaker G: Green fluorescent protein variants as markers of retroviral-mediated gene transfer in primary hematopoietic cells and cell lines. Biochem Biophys Res Commun 234:371, 1997
42. Wagemaker G, Visser TP: Erythropoietin-independent regeneration of erythroid progenitor cells following multiple injections of hydroxyurea. Cell Tissue Kinet 13:505, 1980
43. Wagemaker G: Hematopoietic cell differentiation, in Van Bekkum DW, Löwenberg B (eds): Bone Marrow Transplantation. New York, NY, Dekker, 1985, p l
44. Wagemaker G: Selective multiplication of repopulating hemopoietic stem cells in vitro for bone marrow transplantation. Transplant Proc 19:2721, 1987
45. Markowitz D, Goff S, Bank A: A safe packaging cell line for gene transfer: Separating viral genes on two different plasmids. J Virol 62:1120, 1988
46. Markowitz D, Goff S, Bank A: Construction and use of a safe and efficient amphotropic packaging cell line. Virology 167:400, 1988
47. Topp WC: Normal rat cell lines deficient in nuclear thymidine kinase. Virology 113:408, 1981
48. Rivière I, Brose K, Mulligan RC: Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells. Proc Natl Acad Sci USA 92:6733, 1995
49. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156, 1987
50. Moritz T, Patel VP, Williams DA: Bone marrow extracellular matrix molecules improve gene transfer into human hematopoietic cells via retroviral vectors. J Clin Invest 93:1451, 1994
51. Hanenberg H, Xiao XL, Dilloo D, Hashino K, Kato I, Williams DA: Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells. Nature Med 2:876, 1996
52. Moritz T, Dutt P, Xiao X, Carstanjen D, Vik T, Hanenberg H, Williams DA: Fibronectin improves transduction of reconstituting hematopoietic stem cells by retroviral vectors: Evidence of direct viral binding to chymotryptic carboxy-terminal fragments. Blood 88:855, 1996
53. Leenen PJM, Melis M, Slieker WAT, Van Ewijk W: Murine macrophage precursor characterization. II. Monoclonal antibodies against macrophage precursor antigens. Eur J Immunol 20:27, 1990
54. De Bruijn MFTR, Slieker WAT, Van der Loo JCM, Voerman JSA, Van Ewijk W, Leenen PJM: Distinct mouse bone marrow macrophage precursors identified by differential expression of ER-MP12 and ER-MP20 antigens. Eur J Immunol 24:2279, 1994
55. Van der Loo JCM, Slieker WAT, Kieboom D, Ploemacher RE: Identification of hematopoietic stem cell subsets on the basis of their primitiveness using antibody ER-MP12. Blood 85:952, 1995
56. Merchav S, Wagemaker G: Detection of murine bone marrow granulocyte/macrophage progenitor cells (GM-CFU) in serum free cultures stimulated with purified M-CSF or GM-CSF. Int J Cell Cloning 2:356, 1984
57. Bauman JGJ, Chen MG: Light scatter and cell surface properties of murine megakaryocyte progenitor cells. Exp Hematol 15:1074, 1987
58. Shire D, Calandra B, Rinaldi-Carmona M, Oustric D, Pessègue B, Bonnin-Cabanne O, Le Fur G, Caput D, Ferrara P: Molecular cloning, expression and function of the murine CB2 peripheral cannabinoid receptor. Biochim Biophys Acta 1307:132, 1996
59. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1989
60. Krall WJ, Skelton DC, Yu X-J, Rivière I, Lehn P, Mulligan RC, Kohn DB: Increased levels of spliced RNA account for augmented expression from the MFG retroviral vector in hematopoietic cells. Gene Ther 3:37, 1996
61. Hanazono Y, Dunbar CE, Emmons RVB: Retroviral producer cell lines containing green fluorescent protein S65T vector sequences are unstable: Evidence for toxicity in mammalian cells. Exp Hematol 24:1058, 1996 (abstr)
62. Hanazono Y, Dunbar CE, Emmons RVB: Low titer and high recombination frequency in green fluorescent protein retroviral vector producer cells suggest a selective disadvantage. Blood 88:434a, 1996 (abstr, suppl 1)
63. Van der Loo JCM, Van den Bos C, Baert MRM, Wagemaker G, Ploemacher RE: Stable multilineage hematopoietic chimerism in α-thalassemic mice induced by a bone marrow subpopulation that excludes the majority of day-12 spleen colony-forming units. Blood 83:1769, 1994